跳至主要内容
临床试验/NL-OMON22490
NL-OMON22490已完成不适用

A randomized, double-blind, placebo-controlled trial on the efficacy of oral azithromycin for hospitalised children with respiratory syncytial virus lower respiratory tract disease.

VU university medical centerDr. M.C.J. Kneyber, paediatricianOffice 8 D 11P.O. Box 70571007 MB AmsterdamThe NetherlandsPhone: 003120-4442413Fax: 003120-4443045e-mail: m.kneyber@vumc.nl0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

Pediatr Pulmonol. 2008 Feb;43(2):142-9.

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children <24 months of age with a virologically confirmed diagnosis of RSV lower respiratory tract disease, defined by a first episode of dyspnoea with increased body temperature (> 37.5° C), and/or cough, and/or coryza, and/or wheezing, and/or crackles on pulmonary auscultation.

排除标准

  • Age >24 months, children presenting with apnoea with signs of lower respiratory tract disease, nosocomial RSV infection, antibiotic treatment less than 7 days before hospital admission, abscence of informed consent by parents or legal representatives.

研究者

发起方
VU university medical centerDr. M.C.J. Kneyber, paediatricianOffice 8 D 11P.O. Box 70571007 MB AmsterdamThe NetherlandsPhone: 003120-4442413Fax: 003120-4443045e-mail: m.kneyber@vumc.nl

相似试验